328 related articles for article (PubMed ID: 24530811)
21. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
[TBL] [Abstract][Full Text] [Related]
22. The fate of medium-chain fatty acids in very long-chain acyl‑CoA dehydrogenase deficiency (VLCADD): A matter of sex?
Wehbe Z; Alatibi K; Jellusova J; Spiekerkoetter U; Tucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1591-1605. PubMed ID: 31394165
[TBL] [Abstract][Full Text] [Related]
23. Long-term dietary effects on substrate selection and muscle fiber type in very-long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.
Tucci S; Pearson S; Herebian D; Spiekerkoetter U
Biochim Biophys Acta; 2013 Apr; 1832(4):509-16. PubMed ID: 23313579
[TBL] [Abstract][Full Text] [Related]
24. Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.
Bleeker JC; Kok IL; Ferdinandusse S; van der Pol WL; Cuppen I; Bosch AM; Langeveld M; Derks TGJ; Williams M; de Vries M; Mulder MF; Gozalbo ER; de Sain-van der Velden MGM; Rennings AJ; Schielen PJCI; Dekkers E; Houtkooper RH; Waterham HR; Pras-Raves ML; Wanders RJA; van Hasselt PM; Schoenmakers M; Wijburg FA; Visser G
J Inherit Metab Dis; 2019 May; 42(3):414-423. PubMed ID: 30761551
[TBL] [Abstract][Full Text] [Related]
25. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
26. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
[TBL] [Abstract][Full Text] [Related]
27. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).
Hesse J; Braun C; Behringer S; Matysiak U; Spiekerkoetter U; Tucci S
J Inherit Metab Dis; 2018 Nov; 41(6):1169-1178. PubMed ID: 30194637
[TBL] [Abstract][Full Text] [Related]
29. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
[TBL] [Abstract][Full Text] [Related]
30. Disrupted fat distribution and composition due to medium-chain triglycerides in mice with a β-oxidation defect.
Tucci S; Flögel U; Sturm M; Borsch E; Spiekerkoetter U
Am J Clin Nutr; 2011 Aug; 94(2):439-49. PubMed ID: 21697078
[TBL] [Abstract][Full Text] [Related]
31. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Li X; Ma R; Liu Y; Kang L; He R; Song J; Ren J; Li Y; Huang M; Men J; Yang Y
Clin Chim Acta; 2020 Apr; 503():218-222. PubMed ID: 31794763
[TBL] [Abstract][Full Text] [Related]
32. Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.
Strauss AW; Powell CK; Hale DE; Anderson MM; Ahuja A; Brackett JC; Sims HF
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10496-500. PubMed ID: 7479827
[TBL] [Abstract][Full Text] [Related]
33. A primigravida with very-long-chain acyl-CoA dehydrogenase deficiency.
Murata KY; Sugie H; Nishino I; Kondo T; Ito H
Muscle Nerve; 2014 Feb; 49(2):295-6. PubMed ID: 23966064
[No Abstract] [Full Text] [Related]
34. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
[TBL] [Abstract][Full Text] [Related]
35. Subclinical effects of long-chain fatty acid β-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
Knottnerus SJG; Bleeker JC; Ferdinandusse S; Houtkooper RH; Langeveld M; Nederveen AJ; Strijkers GJ; Visser G; Wanders RJA; Wijburg FA; Boekholdt SM; Bakermans AJ
J Inherit Metab Dis; 2020 Sep; 43(5):969-980. PubMed ID: 32463482
[TBL] [Abstract][Full Text] [Related]
36. Intermittent rhabdomyolysis with adult onset associated with a mutation in the ACADVL gene.
Antunes AP; Nogueira C; Rocha H; Vilarinho L; Evangelista T
J Clin Neuromuscul Dis; 2013 Dec; 15(2):69-72. PubMed ID: 24263034
[TBL] [Abstract][Full Text] [Related]
37. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase.
Exil VJ; Gardner CD; Rottman JN; Sims H; Bartelds B; Khuchua Z; Sindhal R; Ni G; Strauss AW
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1289-97. PubMed ID: 16199475
[TBL] [Abstract][Full Text] [Related]
38. Tissue acylcarnitine status in a mouse model of mitochondrial β-oxidation deficiency during metabolic decompensation due to influenza virus infection.
Tarasenko TN; Cusmano-Ozog K; McGuire PJ
Mol Genet Metab; 2018 Sep; 125(1-2):144-152. PubMed ID: 30031688
[TBL] [Abstract][Full Text] [Related]
39. Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca
Cecatto C; Amaral AU; da Silva JC; Wajner A; Schimit MOV; da Silva LHR; Wajner SM; Zanatta Â; Castilho RF; Wajner M
FEBS J; 2018 Apr; 285(8):1437-1455. PubMed ID: 29476646
[TBL] [Abstract][Full Text] [Related]
40. Treatable massive pericardial effusion and hypertrophic cardiomyopathy in an infant with a novel homozygous ACADVL mutation: A case report.
Kim YM; Kim G; Ko H; Yoo HW; Lee HD
Medicine (Baltimore); 2018 May; 97(20):e10813. PubMed ID: 29768383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]